| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
41.0 |
% |
3.3 |
8.08 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69563 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
0.9% sodium chloride solution (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
155.0 |
um |
8.6 |
21.07 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69570 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
resting tone of middle cerebral artery |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
[(Dmax - Drest) /Dmax] x 100 |
40.0 |
% |
2.1 |
5.56 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69566 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
10 |
|
248.0 |
um |
6.4 |
20.24 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68112 |
732 |
| SS-Shc1em1Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
10 |
|
21.4 |
um |
1.2 |
3.79 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106501 |
3030 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
255.0 |
um |
5.2 |
13.76 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69556 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
245.0 |
um |
8.2 |
20.09 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69559 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
246.0 |
um |
8.9 |
21.8 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69586 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
131.0 |
um |
5.7 |
15.08 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69555 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
157.0 |
um |
2.0 |
4.9 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69573 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
148.0 |
um |
3.7 |
9.06 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69579 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
44.0 |
% |
3.3 |
8.08 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69587 |
732 |
| SS/JrHsdMcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
10 |
|
24.6 |
um |
0.8 |
2.53 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106504 |
3030 |
| SS-Shc1em5Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
8 |
|
24.5 |
um |
1.5 |
4.24 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106507 |
3030 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
10 |
|
145.0 |
um |
3.5 |
11.07 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68111 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
8 |
|
152.0 |
um |
6.1 |
17.25 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69564 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
[(Dmax - Drest) /Dmax] x 100 |
38.0 |
% |
2.1 |
5.56 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69569 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
9 |
|
146.0 |
um |
5.4 |
16.2 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
67244 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
245.0 |
um |
6.1 |
14.94 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69562 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
resting tone of middle cerebral artery |
controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
[(Dmax - Drest) /Dmax] x 100 |
49.0 |
% |
2.4 |
6.35 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69557 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
247.0 |
um |
7.8 |
17.44 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69574 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
255.0 |
um |
2.9 |
6.48 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69583 |
732 |
| SS-Shc1em1Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
5 |
|
23.4 |
um |
1.4 |
3.13 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106496 |
3030 |
| SS-Chr 2BN/Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
8 |
|
21.1 |
um |
0.9 |
2.55 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106495 |
3030 |
| SS/JrHsdMcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
8 |
|
24.1 |
um |
0.8 |
2.26 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106499 |
3030 |
| SS-Shc1em5Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
5 |
|
22.7 |
um |
1.4 |
3.13 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106503 |
3030 |
| SS-Shc1em4Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
4 |
|
24.1 |
um |
2.4 |
4.8 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106502 |
3030 |
| SS-Shc1em4Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
7 |
|
23.9 |
um |
1.6 |
4.23 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106506 |
3030 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
9 |
[(Dmax - Drest) /Dmax] x 100 |
42.0 |
% |
3.3 |
9.9 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
67246 |
732 |
| SS.BN-(D13Rat124-D13Rat101)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
154.0 |
um |
6.6 |
14.76 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68117 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
133.0 |
um |
3.4 |
8.33 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69582 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
138.0 |
um |
10.1 |
24.74 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69585 |
732 |
| SS.BN-(D13Rat77-D13Rat105)/Mcwi |
resting tone of middle cerebral artery |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
42.0 |
% |
1.9 |
4.65 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68116 |
732 |
| SS.BN-(D13Rat124-D13Rat101)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
260.0 |
um |
5.8 |
12.97 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68118 |
732 |
| SS.BN-(D13Rat77-D13Rat105)/Mcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
260.0 |
um |
2.6 |
6.37 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68115 |
732 |
| SS/JrHsdMcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
9 |
|
19.8 |
um |
0.9 |
2.7 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter () |
renal arteriole morphology trait |
106494 |
3030 |
| SS.BN-(D13Rat124-D13Rat101)/Mcwi |
resting tone of middle cerebral artery |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
41.0 |
% |
1.8 |
4.02 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68119 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
147.0 |
um |
2.3 |
6.09 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69567 |
732 |
| SS-Shc1em4Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
5 |
|
21.7 |
um |
0.8 |
1.79 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106497 |
3030 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
9 |
|
252.0 |
um |
3.4 |
10.2 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
67245 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
248.0 |
um |
7.1 |
18.78 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69565 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
237.0 |
um |
6.6 |
17.46 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69568 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
|
156.0 |
um |
3.9 |
10.32 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69558 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
0.9% sodium chloride solution (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
249.0 |
um |
8.5 |
20.82 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69571 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
37.0 |
% |
1.5 |
3.35 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69575 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
246.0 |
um |
3.7 |
8.27 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69577 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
246.0 |
um |
10.5 |
25.72 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69580 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
resting tone of middle cerebral artery |
controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
10 |
[(Dmax - Drest) /Dmax] x 100 |
41.0 |
% |
3.2 |
10.12 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68113 |
732 |
| SS-Shc1em5Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
7 |
|
24.1 |
um |
1.7 |
4.5 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106498 |
3030 |
| SS-Chr 2BN/Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
6 |
|
20.8 |
um |
1.0 |
2.45 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106500 |
3030 |
| SS.BN-(D13Rat77-D13Rat105)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
148.0 |
um |
4.4 |
10.78 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
68114 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
|
145.0 |
um |
8.4 |
20.58 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69561 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
0.9% sodium chloride solution (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
38.0 |
% |
2.1 |
5.14 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69572 |
732 |
| SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
|
113.0 |
um |
4.2 |
9.39 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69576 |
732 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
resting tone of middle cerebral artery |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
39.0 |
% |
1.7 |
4.16 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69581 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
48.0 |
% |
1.9 |
4.25 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69584 |
732 |
| SS/JrHsdMcwi |
resting tone of middle cerebral artery |
angiotensin II (3 ng/kg/min) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
[(Dmax - Drest) /Dmax] x 100 |
54.0 |
% |
2.2 |
4.92 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69578 |
732 |
| SS-Chr 2BN/Mcwi |
renal afferent arteriole diameter |
controlled sodium chloride content diet (1 %) (between 70 and 91 days) then controlled ex vivo artery perfusion pressure (60 mmHg) (for 0.1 hours) |
Miller B, et al., J Clin Invest. 2016 Jul 1;126(7):2533-46. doi: 10.1172/JCI75079. Epub 2016 Jun 6. |
kidney arteriole morphology trait |
not specified |
91 days-133 days |
6 |
|
20.7 |
um |
1.8 |
4.41 |
ex vivo videomicroscopy |
renal afferent arteriole |
120.0 |
0 |
ex vivo videomicroscopy (MMO:0000319) |
renal afferent arteriole diameter (CMO:0003725) |
renal arteriole morphology trait |
106505 |
3030 |
| SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
resting tone of middle cerebral artery |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then controlled calcium ion content physiological salt solution perfusate (0 %) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
[(Dmax - Drest) /Dmax] x 100 |
37.0 |
% |
2.7 |
6.61 |
ex vivo videomicroscopy |
|
0.0 |
0 |
|
|
|
69560 |
732 |
